Medicare AdvantageCoverageMedium impact
Lymphedema - Diagnosis and Treatment - Medicare Advantage (Revised)
Humana·Oncology, Physical Therapy, Occupational Therapy +3 more·Medicare Advantage
Effective date
Dec 1, 2025
We identified it
Jun 24, 2026
Summary
This is a fresh update to Humana Medicare Advantage's lymphedema diagnosis and treatment policy, effective December 1, 2025. The policy provides comprehensive coverage criteria for lymphedema treatments including compression garments, pneumatic compression devices, bioimpedance spectroscopy, and surgical interventions.
Action Required
Before December 1, 2025: Review and update billing procedures for lymphedema treatments under Humana Medicare Advantage plans. Ensure documentation requirements are met for bioimpedance spectroscopy (CPT 93702) including verification that patient has had axillary or pelvic region lymph nodes removed or damaged. Update prior authorization processes to align with CMS NCD 280.6 requirements for pneumatic compression devices. Train billing staff on new coverage criteria and required documentation standards.